Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hantavirus Infection, Austria
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
We investigated a cohort of 370 patients in Austria with hantavirus infections (7.8% ICU admission rate) and detected 2 cases (cumulative incidence 7%) of invasive pulmonary aspergillosis; 1 patient died. Hantavirus-associated pulmonary aspergillosis may complicate the course of critically ill patients who have hemorrhagic fever with renal syndrome.
Citing Articles
Cheng H, Lin C, Lin H, Lin S, Hsieh M, Fang Y Front Cell Infect Microbiol. 2025; 14:1471298.
PMID: 39872946 PMC: 11770025. DOI: 10.3389/fcimb.2024.1471298.
References
1.
Rasmuson J, Pourazar J, Mohamed N, Lejon K, Evander M, Blomberg A
. Cytotoxic immune responses in the lungs correlate to disease severity in patients with hantavirus infection. Eur J Clin Microbiol Infect Dis. 2016; 35(4):713-21.
PMC: 4819462.
DOI: 10.1007/s10096-016-2592-1.
View
2.
Avsic-Zupanc T, Saksida A, Korva M
. Hantavirus infections. Clin Microbiol Infect. 2014; 21S:e6-e16.
DOI: 10.1111/1469-0691.12291.
View
3.
Koehler P, Bassetti M, Chakrabarti A, Chen S, Colombo A, Hoenigl M
. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020; 21(6):e149-e162.
PMC: 7833078.
DOI: 10.1016/S1473-3099(20)30847-1.
View
4.
Hatzl S, Reisinger A, Posch F, Prattes J, Stradner M, Pilz S
. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study. Crit Care. 2021; 25(1):335.
PMC: 8441945.
DOI: 10.1186/s13054-021-03753-9.
View
5.
Apostolopoulou A, Clancy C, Skeel A, Nguyen M
. Invasive Pulmonary Aspergillosis Complicating Noninfluenza Respiratory Viral Infections in Solid Organ Transplant Recipients. Open Forum Infect Dis. 2021; 8(11):ofab478.
PMC: 8600160.
DOI: 10.1093/ofid/ofab478.
View